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Abstract
Background: Patients with type 2 diabetes mellitus (T2D) often experienced change in life, altered self-esteem and
increased feelings of uncertainty about the future that challenge their present existence and their perception of
quality of life (QoL). There was a dearth of data on the association between diabetes-related distress (DRD) and
health-related quality of life (HRQoL). This study examined the determinants of HRQoL, in particular the association
between DRD and HRQoL by taking into account the socio-demographic-clinical variables, including depressive
symptoms (DS) in adult patients with T2D.
Methods: This cross-sectional study was conducted in 2012–2013 in three public health clinics in Malaysia. The
World Health Organization Quality of Life-Brief (WHOQOL-BREF), 17-items Diabetes Distress Scale (DDS-17), and
9-items Patient Health Questionnaire (PHQ-9) were used to measure HRQoL, DRD and DS, respectively. The aim of
this research was to examine the association between the socio-demographic-clinical variables and HRQoL as well
as each of the WHOQOL-BREF domain score using multivariable regression analyses.
Results: The response rate was 93.1 % (700/752). The mean (SD) for age was 56.9 (10.18). The majority of the
patients were female (52.8 %), Malay (53.1 %) and married (79.1 %). About 60 % of the patients had good overall
HRQoL. The mean (SD) for Overall QoL, Physical QoL, Psychological QoL, Social Relationship QoL and Environmental
QoL were 61.7 (9.86), 56.7 (10.64), 57.9 (11.73), 66.8 (15.01) and 65.3 (13.02), respectively. The mean (SD) for the total
DDS-17 score was 37.1 (15.98), with 19.6 % (136/694) had moderate distress. DDS-17 had a negative association
with HRQoL but religiosity had a positive influence on HRQoL (B ranged between 3.07 and 4.76). Women, especially
younger Malays, who had diabetes for a shorter period of time experienced better HRQoL. However, patients who
were not married, had dyslipidaemia, higher levels of total cholesterol and higher PHQ-9 scores had lower HRQoL.
Macrovascular complications showed the largest negative effect on the overall HRQoL (adjusted B = −4.98,
95 % CI −8.56 to −1.40).
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Conclusion: The majority of primary care adult with T2D had good overall HRQoL. Furthermore, the independent
determinants for HRQoL had also concurred with many past studies. In addition, the researchers found that DRD
had negative effects on HRQoL, but religiosity had positive influence on HRQoL. Appropriate support such as
primary care is needed for adult patients with T2D to improve their life and their HRQoL.
Trial registration: NMRR-12-1167-14158
Keywords: Quality of life, Distress, Depression, Type 2 diabetes mellitus, Primary care, Religious beliefs
Background
Type 2 diabetes mellitus (T2D) has been known to have
changed life experiences, altered self-esteem, challenged
present existence and increased uncertainty about the
future [1–8].
The lives of individuals would change from the moment
when they experience the symptoms such as chronic
hyperglycaemia, weight loss, skin infections and lethargy
right up to the diagnosis of diabetes mellitus. A complete
change in life routines continues from the demands of
more regular healthy life-styles, adherence to daily medi-
cation and scheduled visits to various types of healthcare
professionals. Repeated physical examinations, laboratory
tests and psychosocial counselling reverberating the ideas
of risky threats to bodily health and the long-term com-
plications [9] could reduce the self-esteem and self-
confidence that inspire adventures and motivation in the
patients’ lives [10, 11]. Family members and friends would
also avoid discussing the implications of the disease with
the patients [12, 13]. There might be occasional feelings of
stigmatisation at family gatherings or even at work-related
social functions [7, 14]. Left alone to these physical and
psychological onslaughts, many patients may feel over-
whelmed, shaken and questioned their personal values
and beliefs of the purpose of self-regulation [10], self-care
and self-management [15]. Hope for the future may be re-
placed with dread of complications from the disease and
the adverse effects of medications which may result in fre-
quent and disruptive effects such as restlessness, distress,
anxiety, and depression [3, 16]. Eventually, all of these
negative emotions may lead to the failure of adherence to
health recommendations, medications, medical follow-ups
[17, 18], and may increase the number of medical leaves
[16]. Consequently, patients’ personal perceptions turn
from bad to worse, and they start to smoke excessively
[19], practise uncontrolled diet, and have conflicts with
their significant others [20]. This would cause the symp-
toms of diabetes and their associated complications to re-
turn despite escalating their medications [21].
Quality of life (QoL) of the patients with diabetes mel-
litus represents personal perceptions of life experience,
social, vocational and domestic functioning against hope
and ideals from aspects of physical, psychological, rela-
tionships, environmental and spiritual domains [22, 23].
A large body of literature has focused on the impacts of
diabetes mellitus of both type 1 and type 2 on patients,
albeit in vast aspects and contexts of life [4, 21, 24], and
the associations with QoL, self-efficacy and disease con-
trol for adult patients with T2D. Moreover, patients who
perceived higher levels of QoL also showed that they
had better social support, acceptance of the seriousness
and consequences of the disease, and had less difficulty
in managing their diabetes [25]. In spite of the many differ-
ent QoL scales used in past studies, there are similar effects
of socio-demographic variables and clinical parameters on
the domains of QoL across the globe [18, 26–34]. However,
there was a dearth of data on the association between
diabetes-related distress (DRD) and health-related quality
of life (HRQoL). Accordingly, the purpose of this study
was to evaluate the determinants of HRQoL, particularly
to examine the effects of DRD on HRQoL taking into ac-
count other socio-demographic-clinical variables of adult
patients with T2D who received regular primary medical
care in three public health clinics in Malaysia. Hence, the
research question was: what are the independent effects of
socio-demographic-clinical variables, including DRD and
depressive symptoms (DS), on HRQoL in adult patients
with T2D?
Methods
Ethics, consent and permission
This cross-sectional study was approved by the Medical
Research Ethics Committee (MREC), Malaysia’s Ministry
of Health with the reference number NMRR-12-1167-
14158. Respondents had provided their written informed
consent before participating in the study, and the ano-
nymity of the patients was preserved throughout the
study.
Setting
Participants were recruited from three public health clinics:
Seri Kembangan Health Clinic (SK), Dengkil Health Clinic
(DK) and Salak Health Clinic (SL) in Malaysia. These
health clinics were chosen because they were different in
terms of the patients’ characteristics and geographical re-
gions. SK is an urban clinic located in the vicinity of the
Chinese community, and thus it is visited mainly by
Chinese patients. DK is a rural clinic frequented mostly by
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Indians in a larger proportion than a usual public health
clinic. SL is a rural clinic situated in a Malay-majority resi-
dential area. The variability of the sites provided a broad
range of patients on which the associations of DRD,
HRQoL and socio-demographic clinical parameters can
be assessed. The purpose of this report was to determine
the associations of the independent variables and the de-
pendent variables irrespective of the health clinics.
Patient
Definitions of study participants
The researchers had sampled consecutively all the patients
with T2D who came to the clinics. The patients were at
least 30 year-old and were diagnosed with T2D for more
than a year. The patients who were recruited for this study
fulfilled the following criteria: have been on regular
follow-ups, had at least three visits at the clinic in the past
1 year and had recent blood test results done within the
past 3 months. Patients who were pregnant or lactating,
had psychiatric/psychological disorders that could impair
judgment and memory, and could not read or understand
English, Malay or Mandarin were excluded from this
study. Patients who fulfilled the criteria were approached
and informed of the study and their written consents were
obtained before the questionnaires were administered in
their preferred language. Trained research assistants also
interviewed the patients who were not able to answer the
questionnaires themselves.
Besides a questionnaire on demography (age, gender,
ethnicity, religion, educational level, occupation, monthly
income, self-perceive social support) and smoking status,
a structured case record form was used to document the
patients’ history which includes co-morbidities (hyperten-
sion and hyperlipidaemia/dyslipidaemia), diabetes-related
complications, duration of the diabetes, HbA1c, blood
pressure, lipid profiles, number and type of medication
used. Three questionnaires were distributed to evaluate
HRQoL, DRD and DS, and they were prepared in three
languages: English, Malay and Mandarin.
Definitions of diseases
The definition of T2D was when their case records fulfilled
any of these criteria: (i) either having documented a diag-
nosis of diabetes mellitus according to the 1999 World
Health Organization criteria [35] or (ii) currently treated
with lifestyle modifications, oral anti-hyperglycaemic
agents or insulin. Hypertension was diagnosed if the sys-
tolic blood pressure was ≥ 130 mm Hg and/or the diastolic
blood pressure was ≥ 80 mm Hg on two of the successive
readings obtained by the clinic’s physicians. A blood pres-
sure (BP) < 130/80 mmHg was regarded as controlled BP,
and this was the mean of the two readings in the rested
position with the arm positioned at the heart level, using a
cuff of an appropriate size. Hyperlipidaemia refers to an
increase in the concentration of one or more plasma or
serum lipids, usually caused by cholesterol and triglycer-
ides, and the term dyslipidaemia was used for either an in-
crease or decrease in the concentration of one or more
plasma or serum lipids [a low density lipoprotein-
cholesterol (LDL-C) > 2.6 mmol/L, triglyceride (TG) >
1.7 mmol/L and high density lipoprotein-cholesterol
(HDL-C) < 1.1 mmol/L]. Body mass index (BMI) was cal-
culated as weight was divided by height squared. A LDL-
C ≤ 2.6 mmol/L and HbA1c ≤ 6.5 % were regarded as the
other treatment targets [36, 37]. These clinical data
were retrieved from the patient’s medical records
using a case record form on the same day when the
patient completed the questionnaires.
Definitions of diabetes-related complications
There were five diabetes-related complications in this
study. Three were classified as microvascular complica-
tions (MicroCx) which comprised retinopathy, nephropa-
thy, and diabetic foot problems (DFP). Another two
complications were classified as macrovascular complica-
tions (MacroCx) which comprised ischemic heart disease
and cerebrovascular disease, or stroke. These complica-
tions were retrieved from the patient’s medical records.
Diagnoses of these complications were made or confirmed
by the attending physicians at the clinics based on the
medical symptoms, laboratory results, radiological evi-
dence, and treatment history obtained from the clinic and
other hospitals. Nephropathy was diagnosed if any of the
following was present: microalbuminuria, proteinuria,
serum creatinine > 150 mmol/L or estimated glomerular
filtration rate < 60mls/min (calculated using Cockroft-
Gault formula) persisted (≥2 occasions with at least 3
months apart). DFP comprised foot deformity, current
ulcer, amputation, peripheral neuropathy, or peripheral
vascular disease.
Instruments
Health-related quality of life
The World Health Organization Quality of Life- Brief
(WHOQOL-BREF) was chosen in this study as the
HRQoL measure. Although it is not diabetes-specific, it
is relevant to people with diabetes [22]. The WHOQOL-
BREF was developed internationally, cross-culturally and
produces four HRQoL domains [38]. The four domain
scores denote an individual’s perception of HRQoL in
the following domains: Physical (PQOL), Psychological
(YQOL), Social Relationships (SRQOL) and Environment
(EQOL). The sum of these domain scores produces
the overall quality of life (OQOL) [39]. This four-
domain structure has the comparative fit index of
0.901, which demonstrates a good internal consistency
with Cronbach alpha values for each of the four do-
main scores which ranged from 0.66 (for domain 3)
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to 0.84 (for domain 1) [39, 40]. There are also two
items on overall perceptions of HRQoL that are ex-
amined separately. Question 1 asks about the individ-
ual’s overall perception of HRQoL, and question 2 asks
about the individual’s overall perception of his or her health.
Each item, from item number 3 to 26, contributes
equally to their domain score. After the negatively framed
constituent questions were reverse scored, domain scores
were calculated by computing the mean of the item scores
within the domain. The mean domain scores were then
multiplied by 4 providing a range of 4 to 20 and trans-
formed to 100 ([score – 4] * 100/16) in further analyses.
The sum of the domain scores were scaled in a positive dir-
ection (i.e. higher scores denote higher HRQoL). Where up
to two items were missing, the mean of the other items in
the domain were substituted. Where more than 20 % of
the data were missing from an assessment, the assessment
was discarded. Where more than two items were missing
from the domain, the domain score was not calculated
(with the exception of domain 3, where the domain was
only calculated if < 1 item was missing). There were high
correlations between the domain scores based on the
WHOQOL-100 and domain scores calculated using items
in the WHOQOL-BREF [39]. These correlations ranged
from 0.89 (for domain 3) to 0.95 (for domain 1). The
WHOQOL-BREF was shown to be comparable to the
WHOQOL-100 which could discriminate between the ill
and well groups [38, 39].
Diabetes-Related Distress (DRD)
The 17-item Diabetes Distress Scale (DDS-17) assesses
problems and hassles concerning diabetes in the past 1
month on a Likert scale which had measurements of 1
(not a problem) to 6 (a very serious problem) [41]. The
total DDS-17 score ranges from 17 to 102. The score
was calculated by summing up the patient’s responses to
the appropriate items and divided by the number of
items in that scale. A mean item score of ≥ 3 (moderate
distress) is considered a level of distress worthy of clin-
ical attention. The DDS-17 has been found to have ad-
equate and better psychometric properties compared to
other similar scales [42]. A local translation and valid-
ation study of the Malay version of DDS-17 showed a
high internal consistency (Cronbach’s α = 0.94) and test–
retest reliability value of 0.33 (P = 0.009) [43]. There was
a significant relationship between the mean DDS-17
item score categories (<3 vs ≥ 3) and HbA1c categories
(<7 % vs ≥ 7 %) (X2 = 4.20; P = 0.048). The DDS-17 sensi-
tivity and specificity, with positive and negative predict-
ive values were 56.5, 23.8, 7.6 and 83.1 %, respectively. A
Chinese version of the DDS-17 was found to have good
psychometric properties with Cronbach’s α of 0.90 for
internal consistency and test–retest reliability coefficient
of 0.74 [44].
Depressive Symptoms (DS)
The Patient Health Questionnaire (PHQ-9) has been
known to have a good construct and criterion validity in
making diagnosis and assessing the severity of DS, of
which a total score of ≥ 10 indicates a sensitivity of 88 %
and a specificity of 89 % for major DS [45]. The PHQ-9
refers to the symptoms experienced by patients during
the 2 weeks prior to answering the questionnaire (for
example thoughts that you would be better off dead or
of hurting yourself in some way). The PHQ-9 scores
range from 0 to 27, and each of the nine items has a
score starting from 0 (not at all) to 3 (nearly every day).
PHQ-9 scores of 0–4, 5–9, 10–14, 15–19, and 20–27
represent none to minimal, mild, moderate, moderately
severe, and severe DS, respectively. The Malay version of
PHQ-9 had been locally validated with a sensitivity of
87 % (95 % confidence interval 71 to 95 %), a specificity
of 82 % (74 to 88 %), positive likelihood ratio (LR) 4.8
(3.2, 7.2) and negative LR 0.16 (0.06, 0.40) [46]. DS was
included in this study as one of the main covariates of
DRD [47]. The Chinese version of the PHQ-9 is reported
to have good psychometric properties with an internal
consistency of 0.82 and test–retest reliability of 0.76 over
a 2-week interval [48].
Statistical analyses
A sample size was calculated using GPower 3.1.2 soft-
ware with an estimated effect size at 1.5 [47, 49], of
DRD on HRQoL, with a power of 0.95 and significance
at 0.05; the estimated sample size was 500. Taking into
consideration the fact that 30 % of the data in the
patient’s medical records were either incomplete or miss-
ing, and 30 % of the data in the questionnaires filled by
the patients were incomplete, and the sample size needed
was 650.
Quantitative data analyses were then executed with
IBM SPSS Statistics version 21.0. Comparisons of mean
levels were performed using the Student’s t-test for
unpaired samples and Chi square test was used for pro-
portionate samples. If the value of P < 0.05, it was consid-
ered to be significant at two tails. Independent variables
include the demographic, DRD (measured by DDS-17),
DS (measured by PHQ-9), and clinical data.
The researchers had observed that the socio-
demographic characteristic was according to the tertile
of the overall quality of life (OQOL). Visual inspections
on the histogram and the statistical tests confirmed the
normal distributions of OQOL and the four domain scores
(PQOL, YQOL, SRQOL and EQOL). Then the relationship
between the independent variables towards OQOL and
each of the domain score were examined using multiple
linear regression analyses.
Univariable analyses were executed for all the studied
variables and the variables that showed significant effects
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on the WHOQOL-BREF scores were included in the final
multiple linear regression analyses. Socio-demographic
data that were continuous and ordinal were entered in the
linear regression while the nominal variables were trans-
formed to binary (such as ethnicity, religion and marital
status). Employment status variable was re-ordered into
three categories: unemployed (0), retired/home manager
(1) and employed (2) based on the initial assessments of
the direction of the effect on WHOQOL-BREF scores.
Clinical variables that had intervals were first entered in
the linear regression. The absence of association prompted
the entry of the clinical variables to be in a binary nature
in accordance to the recommended targets of control (1).
MicroCx and MacroCx were preferentially entered in
sequence in the linear regression analyses instead of
the combined variable of any diabetes complications
which was only entered when both the MicroCx and
MacroCx were found not in association with HRQoL.
This was done so that the individual effects of
MicroCx or MacroCx could be discovered, and the
combined variable for both of these complications
would confirm the true state of no association with a
larger sample size.
The multicollinearity between the variables was
checked with a correlation matrix and an inspection of
their standard error (SE) magnitude. In this study, no
variables correlated with each other, r < 0.2 and SEs
were all within 0.001 to 5.0. In all the final models, Q-Q
plots gave an indication of normality, the residual plots in-
dicated a fulfilment of linearity and homogeneity assump-
tions. Age, gender and ethnicity were included in all the
models because these three variables were potential
confounders.
Results
The participants’ response rate was 93.1 % (700/752). Out
of these respondents, 694, 700, 697 and 698 had complete
data on summed OQOL, PQOL, YQOL, SRQOL and
EQOL, respectively. The mean (SD) for age was 56.9
(10.18) years. More than half were women (52.8 %) and
Malay (53.1 %) (Table 1). Furthermore, the majority of the
respondents were either married or living with partners
(79.1 %), had non-tertiary education (89.0 %), and were
earning < RM 3000 (about USD 850) per month (94.4 %).
Most patients did some exercise (57.6 %) and never
smoked (76.1 %). About 80 % of the patients reported
that they had hypertension compared to about 40 %
who had dyslipidaemia. Patients who used oral hypogly-
caemic (OHA), anti-hypertensive agents (AHA), and lipid-
lowering agents (LLA) were about 91 %, 88 % and 77 %, re-
spectively (Table 1).
There were only a minority of patients who achieved
treatment targets. About 10 % attained BMI < 23 kgm−2,
15 % achieved HbA1c < 6.5 %, 25 % achieved HbA1c <
7.0 %, 30 % attained BP ≤ 130/80 mmHg and 40 % attained
LDL-C ≤ 2.6 mml/L (Table 1). In addition, about 12 % had
one of the diabetes-related complications, and this rate
seemed to parallel with the number of patients who were
on anti-platelet agents (Table 1).
Based on the first two items of the WHOQOL-BREF, a
majority of the adult patients with T2D at the primary
care clinics had good HRQoL. About 60 % of the respon-
dents had more than good overall HRQoL and were satis-
fied with their health (Fig. 1). The mean (SD) for OQOL,
PQOL, YQOL, SRQOL and EQOL were 61.7 (9.86), 56.7
(10.64), 57.9 (11.73), 66.8 (15.01) and 65.3 (13.02), respect-
ively. The patterns of distribution for WHOQOL-BREF
domains in the three participating clinics were largely
similar with PQOL and YQOL at the trough, and SRQOL
and EQOL at the peak (Fig. 2). Patients from SL health
clinic showed a significantly higher HRQoL. This associ-
ation disappeared after the other socio-demographic
variables were adjusted in the multivariable analyses
(Table 2).
Socio-demographic profile and quality of life
Male patients with T2D were generally experienced lower
HRQoL except in PQOL and significantly so in SRQOL
(Table 2). However, Malay patients had significantly better
EQOL except in PQOL and YQOL (Table 2). Patients
who were older and had diabetes for a longer duration
had negative impacts on HRQoL in almost all of the
sub-domains which was statistically significant with
the SRQOL domain (Table 2). We observed that being re-
ligious was a socio-demographic variable that had the lar-
gest positive and independent effects on OQOL (B = 3.07),
PQOL (B = 3.22) and YQOL (B = 4.76) (Table 2). Also,
being employed as compared to those unemployed and re-
tired, was a significant independent determinant of OQOL
(B = 2.08) and PQOL (B = 2.34). Patients who exercised
more frequently per week perceived higher OQOL (ad-
justed B = 1.31), SRQOL (adjusted B = 2.38), and EQOL
(adjusted B = 1.99).
Clinical parameters and quality of life
Having co-morbidities and diabetes-related complica-
tions would reduce WHOQOL-BREF scores (Table 2).
Dyslipidaemia was shown to have significant independ-
ent negative impacts on YQOL (B = −3.14) and EQOL
(B = −2.78). Although hypertension showed a positive ef-
fect on SRQOL (Table 2), MacroCx caused consistent
negative and independent effects on HRQoL, OQOL
(B = −4.98, 95 % CI −8.56 to −1.40) and EQOL (B = −4.38,
95 % CI −8.30 to −0.46).
In general, clinical biomarkers of disease condition
and control had negative associations with HRQoL
perception. The examples include HDL-C on PQOL
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Table 1 The socio-demographic and clinical characteristics according to the tertile of the World Health Organization Quality of Life- Brief
(WHOQOL-BREF)
Tertile WHOQoL-BREF total score, n (%) X2 P*
Totala Lowb Intermediateb Highb
Health Clinic Seri Kembangan 218 (31.4) 79 (36.2) 75 (34.4) 64 (29.4) 12.40 0.015
Dengkil 123 (17.7) 43 (35.0) 50 (40.7) 30 (24.4)
Salak 353 (50.9) 107 (30.3) 107 (30.3) 139 (39.4)
Age, year ≤50 186 (26.9) 62 (33.3) 52 (28.0) 72 (38.7) 5.90 0.206
51–60 268 (38.7) 90 (33.6) 88 (32.8) 90 (33.6)
>60 238 (34.4) 76 (31.9) 91 (38.2) 71 (29.8)
Diabetes Duration, year <5 341 (50.8) 111 (32.6) 106 (31.1) 124 (36.4) 8.61 0.072
5–9.9 187 (27.9) 58 (31.0) 60 (32.1) 69 (36.9)
≥10 143 (21.3) 52 (36.4) 57 (39.9) 34 (23.8)
Gender Female 365 (52.8) 120 (32.9) 127 (34.8) 118 (32.3) 0.79 0.673
Male 326 (47.2) 106 (32.5) 105 (32.2) 115 (35.3)
Ethnicity Malay 365 (53.1) 109 (29.9) 120 (32.9) 136 (37.3) 16.48 0.002
Chinese 160 (23.3) 73 (45.6) 46 (28.8) 41 (25.6)
Indian 163 (23.7) 46 (28.2) 62 (38.0) 55 (33.7)
Religion No religion 32 (4.6) 13 (40.6) 10 (31.3) 9 (28.1) 26.22 0.003
Moslem 373 (53.9) 109 (29.2) 124 (33.2) 140 (37.5)
Buddhist 81 (11.7) 45 (55.6) 19 (23.5) 17 (21.0)
Hinduism/Sikh 147 (21.2) 41 (27.9) 57 (38.8) 49 (33.3)
Christian/Catholic 22 (3.2) 7 (31.8) 7 (31.8) 8 (36.4)
Others 37 (5.3) 13 (35.1) 14 (37.8) 10 (27.0)
Religiosity Religious 590 (85.5) 183 (31.0) 197 (33.4) 210 (35.6) 11.95 0.018
Unsure 24 (3.5) 13 (54.2) 9 (37.5) 2 (8.3)
Not religious 76 (11.0) 31 (40.8) 25 (32.9) 20 (26.3)
Marital status Married/living with a partner 546 (79.1) 176 (32.2) 184 (33.7) 186 (34.1) 4.69 0.584
Widowed 97 (14.1) 30 (30.9) 35 (36.1) 32 (33.0)
Divorced/separated 21 (3.0) 11 (52.4) 4 (19.0) 6 (28.6)
Single 26 (3.8) 10 (38.5) 8 (30.8) 8 (30.8)
Education Never 45 (6.6) 18 (40.0) 16 (35.6) 11 (24.4) 7.15 0.128
Primary & secondary 563 (82.4) 185 (32.9) 195 (34.6) 183 (32.5)
Tertiary 75 (11.0) 22 (29.3) 19 (25.3) 34 (45.3)
Employment Retired/home manager 368 (53.3) 127 (34.5) 131 (35.6) 110 (29.9) 7.64 0.106
Employed 312 (45.2) 95 (30.4) 98 (31.4) 119 (38.1)
Unemployed 11 (1.6) 6 (54.5) 2 (18.2) 3 (27.3)
Income (RM) <1000 323 (47.4) 113 (35.0) 101 (31.3) 109 (33.7) 3.32 0.506
1000–2999 320 (47.0) 99 (30.9) 115 (35.9) 106 (33.1)
≥3000 38 (5.6) 9 (23.7) 14 (36.8) 15 (39.5)
Exercise No 293 (42.5) 112 (38.2) 91 (31.1) 90 (30.7) 10.94 0.027
≤3 times in a week 231 (33.5) 77 (33.3) 79 (34.2) 75 (32.5)
>3 times in a week 166 (24.1) 39 (23.5) 60 (36.1) 67 (40.4)
Smoking Never 526 (76.1) 177 (33.7) 175 (33.3) 174 (33.1) 5.14 0.273
Stop > 5 years 60 (8.7) 20 (33.3) 14 (23.3) 26 (43.3)
Stop≤ 5 years and active smoker 105 (15.2) 32 (30.5) 41 (39.0) 32 (30.5)
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Table 1 The socio-demographic and clinical characteristics according to the tertile of the World Health Organization Quality of Life- Brief
(WHOQOL-BREF) (Continued)
BMI, Kgm−2 <23.0 76 (11.2) 32 (42.1) 22 (28.9) 22 (28.9) 7.75 0.101
23.0–27.4 237 (35.0) 82 (34.6) 82 (34.6) 73 (30.8)
≥27.5 365 (53.8) 103 (28.1) 125 (34.2) 137 (37.5)
HbA1c, % HbA1c≥ 6.5 515 (83.3) 168 (32.6) 171 (33.2) 176 (34.2) 0.26 0.879
HbA1c <6.5 103 (16.7) 36 (35.0) 34 (33.0) 33 (32.0)
HbA1c≥ 7.0 455 (73.6) 148 (32.5) 153 (33.6) 154 (33.8) 0.23 0.892
HbA1c <7.0 163 (26.4) 56 (34.4) 52 (31.9) 55 (33.7)
Hypertension No 148 (21.7) 46 (31.1) 45 (30.4) 57 (38.5) 1.71 0.426
Yes 534 (78.3) 180 (33.7) 179 (33.5) 175 (32.8)
BP, mmHg BP > 130/80 479 (69.5) 155 (32.4) 155 (32.4) 169 (35.3) 1.53 0.466
BP ≤130/80 210 (30.5) 72 (34.3) 74 (35.2) 64 (30.5)
Dyslipidaemia No 406 (60.9) 124 (30.5) 125 (30.8) 157 (38.7) 9.94 0.007
Yes 261 (39.1) 95 (36.4) 96 (36.8) 70 (26.8)
LDL-C, mmol/L LDL-C > 2.6 336 (59.9) 106 (31.5) 120 (35.7) 110 (32.7) 2.72 0.257
LDL-C≤ 2.6 225 (40.1) 74 (32.9) 66 (29.3) 85 (37.8)
HDL-C, mmol/L HDL-C < 1.1 407 (72.2) 118 (29.0) 143 (35.1) 146 (35.9) 5.86 0.053
HDL-C≥ 1.1 157 (27.8) 62 (39.5) 45 (28.7) 50 (31.8)
TG, mmol/L TG > 1.7 250 (44.3) 81 (32.4) 85 (34.0) 84 (33.6) 0.36 0.837
TG ≤1.7 314 (55.7) 99 (31.5) 102 (32.5) 113 (36.0)
Total-C, mmol/L Total-C > 4.5 357 (58.1) 121 (33.9) 126 (35.3) 110 (30.8) 4.81 0.090
Total-C≤ 4.5 257 (41.9) 78 (30.4) 78 (30.4) 101 (39.3)
Any diabetes complication No 608 (87.7) 193 (31.7) 201 (33.1) 214 (35.2) 6.31 0.043
Yes 85 (12.3) 36 (42.4) 30 (35.3) 19 (22.4)
Microvascular complication No 641 (92.5) 207 (32.3) 212 (33.1) 222 (34.6) 4.23 0.120
Yes 52 (7.5) 22 (42.3) 19 (36.5) 11 (21.2)
Macrovascular complication No 648 (93.9) 206 (31.8) 217 (33.5) 225 (34.7) 6.92 0.031
Yes 42 (6.1) 21 (50.0) 13 (31.0) 8 (19.0)
OHA No 60 (8.7) 25 (41.7) 20 (33.3) 15 (25.0) 3.03 0.220
Yes 630 (91.3) 202 (32.1) 210 (33.3) 218 (34.6)
Insulin No 422 (61.2) 132 (31.3) 139 (32.9) 151 (35.8) 2.27 0.687
1 type 187 (27.1) 66 (35.3) 64 (34.2) 57 (30.5)
2 types 80 (11.6) 29 (36.3) 26 (32.5) 25 (31.3)
Number of AHA agents No 81 (11.8) 22 (27.2) 30 (37.0) 29 (35.8) 4.71 0.581
1 type 204 (29.6) 70 (34.3) 65 (31.9) 69 (33.8)
2 types 203 (29.5) 73 (36.0) 59 (29.1) 71 (35.0)
3 types 201 (29.2) 62 (30.8) 75 (37.3) 64 (31.8)
LLA No 156 (22.6) 50 (32.1) 47 (30.1) 59 (37.8) 1.59 0.451
Yes 533 (77.4) 177 (33.2) 182 (34.1) 174 (32.6)
APA No 612 (89.1) 194 (31.7) 202 (33.0) 216 (35.3) 6.48 0.039
Yes 75 (10.9) 32 (42.7) 27 (36.0) 16 (21.3)
*Chi-square P value
BP blood pressure, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglycerides, Total-C total cholesterol, AHA anti-
hypertensive agent, BMI body mass index, BP blood pressure, APA anti-platelet agent, OHA oral hypoglycaemic agent, LDL-C low density lipoprotein- cholesterol,
HDL-C high density lipoprotein- cholesterol, LLA lipid-lowering agent, RM Ringgit Malaysia, TG triglyceride, Total-C total-cholesterol, WHOQoL-BREF World Health
Organization Quality of Life-Brief 26 items
aColumn percentage
bRow percentage
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(B = −4.51) and Total-C on EQOL (B = −1.04). Pa-
tients who were on OHA compared to those not tak-
ing any OHA were reported to have better HRQoL,
and the most significant positive effect was seen on
PQOL (Table 2).
Diabetes-related distress, depressive symptoms and
quality of life
The mean (SD) for total DDS-17 score was 37.1 (15.98)
with 19.6 % (136/694) had moderate distress. Both








How would you rate your
quality of life? N= 700
How satisfied are you with












Fig. 1 The proportion of responses to the first two items of the WHOQOL-BREF on the overall perception of health. WHOQOL-BREF= World
Health Organization Quality of Life- Brief
Fig. 2 The WHOQOL-BREF mean (95 % confidence interval) of the total and domain score according to the three primary healthcare clinics
in Malaysia
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Table 2 The determinants of the health-related quality of life measured by the World Health Organization Quality of Life- Brief (WHOQOL-BREF)
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Bs are unstandardized coefficients
OQOL overall quality of life, PQOL physical quality of life, YQOL psychological quality of life, SRQOL social relationships quality of life, EQOL environment quality of life, AHA anti-hypertensive agent, APA anti-platelet
agent, B Coefficients, CBG casual blood glucose, BMI body mass index, CI confidence interval, DDS diabetes distress scale, MacroCx macrovascular complication, MicroCx microvascular complication, OHA oral
hypoglycaemic agent, PHQ patient health questionnaire, SBP systolic blood pressure, Total-C total cholesterol
aTotal DDS scores range from 17 to 102
bTotal PHQ-9 scores range from 0 to 27




gEducational status = never (0), primary & secondary (1), tertiary and above (2)
hEmployment status = unemployed (0), retired (1), employed (2)



















especially on the YQOL (Table 2). DS showed more con-
sistent, negative and independent effects across all the
domains of HRQoL in comparison with DRD.
Discussion
This study examined the HRQoL and its determinants in
adults with T2D at the primary care level. WHOQOL-
BREF was used instead of the disease-specific measure in
order to determine the wider life impacts of T2D on pa-
tients which was rarely studied in the past. Nevertheless,
in addition to the DS assessment a disease specific meas-
ure for distress, the DDS-17, was included in the present
study.
It was disturbing to find that the mean score for PQOL
was the lowest followed by YQOL. PQOL which repre-
sented physical functions, disability and needs showed that
adult patients with T2D required much care for their pain,
sleep and mobility. They also lacked of support from
others to satisfactorily perform their daily activities. Phys-
ical problems such as pain, discomfort, and diet restric-
tions were also known to cause major problems in adult
patients with T2D who were treated at primary care level
in Singapore [50]. Perhaps more practical and psycho-
logical supports are needed to alleviate their perception
on the burden of taking medication in order to improve
their confidence when performing house chores and
working. The findings on the YQOL domain revealed that
adult patients with T2D experienced negative feelings
(blue moods, despair, anxiety etc.) at primary care level
which resulted in the inability to concentrate or enjoy a
meaningful life. These two domains of poor physical and
mental health had also been reported to have caused a
median of 2 (IQR 0–10) unhealthy days in the past month
among Irish patients with diabetes mellitus [51].
The SRQOL was the least affected among all the
WHOQOL-BREF domains, and this was probably due to
the prevalent of social support [52], culture [53], and
family values such as filial piety in this country and re-
gion [54, 55]. However, these findings and values are not
restricted to this study and region [25]. The perception
on the quality of environment, living conditions, and ac-
cess to transport and healthcare was categorised as mod-
erate to good, and this was probably due to moderate
ways of living and the culture of accepting current situa-
tions or fates. Although these personal attitudes and vir-
tues could pose real barriers to diabetes care [56], it was
uncertain whether having these qualities would help the
patients to face life challenges and contribute to the high
(about one third) responses of neither good nor dissatis-
fied in the first two items of WHOQOL-BREF.
Socio-demographic profile and quality of life
Men with T2D were generally experienced lower HRQoL
and significantly so in SRQOL except in PQOL. It was
possible that these men were almost inherently the
bread-winners of their families and were required to be
out-and-about, and were less likely to complain or per-
ceive themselves to be in need of basic help (just like
men in most cultures). Hence, there was no association
between these men and the physical domain of HRQoL
[57]. In relation to men’s emotional ability [58], it was
noted that they experienced the poorest SRQOL that re-
quired emotional skills for interpersonal relationships
and the management of emotions. These findings were
in contrast to the men with T2D from multi-ethnic
backgrounds (non-Hispanic whites, African-Americans,
Asian-Indians, and Hispanics) in Texas, United States
(US) who were reported to have better diabetes-specific
HRQoL compared to the women [55]. In another study,
women who perceived living with diabetes as predomin-
antly stressful intermingled with depressive feelings were
required to be constantly vigilant about healthy eating,
self-concern, and fatigue [3]. In this study, it was noted
that HRQoL was better perceived by women because
T2D had more adverse impacts on men, or the men’s
perception could be limited by their emotional ability
[58]. However, future studies are needed to confirm this
and to examine the causes of low HRQoL among men
with T2D.
Compared to other ethnic groups, Malay patients had
a significantly better perception of their HRQoL in the
univariable analyses. It was only statistically significant
in the EQOL after the other covariates were adjusted
and was negatively associated with the PQOL and
YQOL domains (not reaching statistical significance). It
was believed that this is closer to the actual states found
in adults with T2D compared to the previous studies
that reported positive association between Malays and
their emotional and mental health status [59–61]. These
past studies were limited by inadequate adjustments
[59], loss of data quality due to the heterogeneity of the
population (not specific to T2D), categorization of con-
tinuous outcome data and data-driven analysis [60, 61].
The Malays experienced better HRQoL, and this could
be due to being more religious and having better social
support network when faced with the external challenges
of living with T2D [53, 60]. Nevertheless, self-care is pa-
tently a personal issue, and the impacts of changed life
routines due to T2D are irrespective of ethnicity as evi-
denced by the non-significant differential effects of eth-
nicity on many HRQoL domains in the multivariable
analyses.
After adjusting for co-morbidities and complications,
this study showed the negative impacts of older age and
having diabetes for a longer duration on HRQoL, espe-
cially on the social relationship domain. In a study in-
volving Greek respondents, a generic SF-36 instrument
was used on T2D patients in a rural setting, and it was
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discovered that women who were older, had diabetes for
a longer duration and were unmarried were the predic-
tors of impaired HRQoL [32]. Similar results were also
reported from a Turkish setting where diabetes-specific
HRQoL assessment tool was used (DQoL) [62], and
T2D patients who were older than 40 year old, men, un-
married, had diabetes for more than 5 years, suffered
from complications or prior hospitalization, and had
HbA1c > 7 %, a significantly poorer overall HRQoL. It
was possible that T2D patients who were older or had
diabetes for a longer duration had higher cardiovascular
risk, were prescribed more medications (and insulin),
had more scheduled visits to different medical specialists,
suffered from more co-morbidities, and complications
which had reduced HRQoL [63]. It was unfortunate that
although social care and support were available [25], the
older patients found themselves inadequate for acceptable
quality of life.
Amongst all the socio-demographic variables, being a
religious person was noted to be the most potent deter-
minant for HRQoL. The salutogenic effects of religiosity
could be linked to the privileged relationship with the
Higher or Supreme Being, stronger spirituality, and hav-
ing a sense of purpose in life, social network and healthy
lifestyles [64–66]. The ability to adhere to one’s religion
and its way of life is defined as religiosity in this study.
A patient must have had some physical agility that en-
abled him/her to attend places of worship and to partici-
pate in ceremonies or rites. Success in fulfilling these
religious requirements might greatly ease any sense of
guilt and improve spiritual well-being that could further
induce a sense of harmony with the Supreme Being and
psychological wellness [67, 68], which indeed is an in-
ternal resource for the self-management of T2D [69, 70].
Spirituality and spiritual support were the constructs
that could relate to DS and affect HRQoL in T2D pa-
tients [71–73]. However, more research is needed to
understand the independent associations of religiosity
and the differential effects of the different religions, on
HRQoL.
Also, it was reassuring to find that being employed
and engaged in high frequency exercise per week con-
tributed to better HRQoL. Most likely active employ-
ment provided economic security and social status, and
the absence of either one or both factors would be detri-
mental to many aspects of human living and quality of
life. Since active employment was generally equated to
higher socio-economic status and education, the effects
of these factors on HRQoL were also reported elsewhere
[30, 32, 33]. In a more optimistic note, patients who
were in active vocations might feel more fulfilled when
completing their jobs or attending job-related engage-
ments which could be lacking if they were in the retire-
ment phase.
Exercise and HRQoL have a multi-level and multi-
dimensional association, and the effects are beneficial to
patients with T2D [74]. In a nationwide survey in the
US, it was observed that a self-reported exercise was the
only significant self-management behaviour to predict
HRQoL after controlling the demographic and medical
variables [26]. Physiologically, exercise or physical activ-
ity stimulates the release of endorphin that induces and
facilitates a sense of elation, relaxation, and well-being
[75]. Psychologically, when T2D patients adhere closely
to the advice to exercise regularly, this may encourage a
sense of compliance and harmonious relationship with
their healthcare professionals and significant others [9].
In return, regular and increased frequency of exercise
could also increase the social connectivity between the
patients, their family members and friends, and also
improve their physical health [76].
Clinical parameters and quality of life
The negative and independent effects of MacroCx on
OQOL were not unexpected because the consequences
of IHD and stroke on patients’ daily life activities are
known to many [29, 77]. In contrast, the more subtle
and minimal the impacts of the early stages of MicroCx
would explain the lack of its effects on HRQoL. Similar
findings were also reported with diabetes patients at pri-
mary care from the Nordic countries [28], Greece [32]
and Malaysia [61]. Although many different QoL mea-
sures were used in these studies, the results showed
consistency and strong negative effects of MacroCx, espe-
cially coronary heart disease on HRQoL while weaker pre-
dictors were MicroCx, older age, women, lower education,
lower income, normotensive and high HbA1c [28].
This study reveals that being diagnosed with dyslipi-
daemia could be more deleterious to YQOL than being
diagnosed with hypertension. Although the effects of
hypertension were expected to be more detrimental to
the patients’ health than the effects of dyslipidaemia [32],
it is intriguing to learn that T2D patients in this study per-
ceived dyslipidaemia as worse than hypertension. It was
possible to learn that dietary changes needed to control
high cholesterol can be burdensome to some people and
might be related to lower YQOL. Further study is needed
to ascertain the possible reason adult patients with T2D
chose dyslipidaemia and not hypertension on the YQOL.
The negative effects of having dyslipidaemia and higher
Total-C on EQOL might arise when patients’ desire for
more physical activities were impeded. This might happen
when patients were faced with non-conducive environ-
ment such as unhealthy weather, lack of sport facilities,
and feeling unsafe when going out of the house. Past stud-
ies had also reported the prevalent association of high
level clinical parameters such as HbA1c, blood pressure
and lipid with lower HRQoL [28, 32, 33]. However, it was
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not uncommon to find the non-association between these
biomarkers and HRQoL, or psychosocial variables such as
social support, self-esteem and psychological well-being
[78–80] in past literature. This discrepancy might be due
to the different HRQoL measures used in the different
studies [22].
It is difficult to hypothesise the negative effects of
lower SBP, HDL-C, and OHA use on WHOQOL-BREF.
For the BP target and HDL-C, it was possible to learn
that that patients who had healthy diets and exercised
regularly faced the physical and external barriers repre-
sented in the PQOL and EQOL domains. In the case of
OHA use and better PQOL, it might be that the use of
OHA had ameliorated the physical symptoms of uncon-
trolled diabetes mellitus leading to improved physical
functioning of daily activities, sleep and concentration.
Similar observations were reported in newly diagnosed
Dutch patients in general practices who showed im-
proved vitality scores and HRQoL following the first year
treatment for their diabetes [81]. A recent systematic re-
view suggested that a greater HRQoL could be gained if
insulin or newer injectable agents (glucagon-like peptide
agonists and analogues, amylin analogues) were added
to the patient’s medication regimen rather than another
OHA (e.g., adding sitagliptin or pioglitazone to metfor-
min only) [82]. Unobserved determinants could probably
explain the associations between treatment targets and
HRQoL, particularly the SBP and its positive effects on
the EQOL, such as the different geographic and social
factors [83], dispositional optimistic personality and goal
adjustment [84]. Also, being less critical to other people’s
comments and having a could-not-care-less attitude to-
wards one’s health [85, 86]. Alternatively, it is also pos-
sible that the indicators of the disease control and health
were relatively less important as compared to MacroCx
and/or MicroCx. the outcomes of poor disease control,
on HRQoL [87] and hence resulted in the diverged asso-
ciations between them.
Diabetes-related distress, depressive symptoms and
quality of life
Both DRD and DS were associated with lower HRQoL,
especially on the YQOL. A Chinese study reported that
emotional distress was the most important explanatory
factor for quality of life which amounted to 28.7–53.8 %
of the total variance [88]. However, this study showed
that DS instead of DRD had a more consistent, negative,
and independent effect across all the domains of HRQoL.
Similar patterns of association were also reported by
Carper et al. who stated that DS severity (assessed with
Montgomery Asberg Depression Rating Scale) was as-
sociated with poorer HRQoL (measured with Quality
of Life Inventory), specifically on the achievement,
psychosocial growth and environment domains while
DRD was associated with poorer HRQoL on the achieve-
ment domain [89]. The results of the present study sug-
gested that DRD and DS were related, but were distinct
constructs [47] associated with the various aspects of
HRQoL that were beyond demographic and clinical
factors.
Sundaram et al. reported the pervasive effects of DS
among adult patients with T2D on a number of QoL
measures that included the generic health status (12-
item Short-Form Health Survey [SF-12] and EQ-5D)
and diabetes-specific QoL (Audit of Diabetes Dependent
Quality of Life) [90]. The degree of diabetes-specific QoL
perception was reported to be associated with the severity
of DS (r = 0.503; p < 0.001) among Brazilian patients with
T2D [78]. Similarly, DS (measured with SF-12 Mental
Component Score) among the elderly German patients
with T2D was one of the independent predictors for
HRQoL [91]. Besides DS, other mental disorders such
as anxiety and schizophrenia had also been reported
to be significant predictors for poorer diabetes-specific
QoL [92].
These findings confirm the past reports on the preva-
lent and intimate relationships between the domains of
HRQoL and emotions (DRD and DS), psychological
well-being, and social functioning in adult patients with
T2D [28]. By providing effective psychological support
for DRD and DS, HRQoL may benefit to a large extent.
Since evidence showed that DRD had preceded DS [93],
and that DRD was both milder and more common in
primary care as compared to DS [94], it would be a wise
therapeutic and preventive opportunity to intervene for
DRD in order to reduce the DS and its distal adverse ef-
fects and complications. An intervention for a relatively
non-complicated psychological disorder such as DRD
could probably be addressed with a less complex
programme and competently delivered by the paramedics.
Limitations and strengths
Adopting a generic measure for HRQoL would cause
some limitations and bring different interpretations. It
was possible for T2D patients to report high levels of
HRQoL in general, but poor HRQoL meant the patients
were impaired by diabetes [95]. During clinical consulta-
tions, when opportunities arise to tailor the treatments
of each T2D patient for the purpose of improving the
patient’s HRQoL, it is essential to differentiate between
the general QoL and disease-specific HRQoL because
patient’s needs might go unnoticed if the general well-
being or QoL are the only outcomes measured, and if it
appeared to be good [96].
The strength of this study includes the relatively
large sample size with high response rate, and it also
represents the study population to the study domain
from the aspects of socio-demographic characteristics
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[97]. Another important strength of the present study is
the use of a validated and specific measure of DRD.
Conclusions
The majority of adult patients with T2D at a primary
care setting had a good overall HRQoL. The independent
determinants for HRQoL concurred with many of the past
studies. In addition, DRD was reported to have negative
effects on HRQoL. Meanwhile, religiosity had positive in-
fluences on HRQoL. Adult patients with T2D who were
men, non-Malay, unmarried, unemployed, from older age
group, had longer duration of diabetes, dyslipidaemia,
MacroCx, did not engage in frequent exercises per week,
had higher levels of Total-C, who experienced DRD and
DS had lower HRQoL needed additional supports. Timely
and less complex psychological intervention at primary
care level could be prioritised for the right and most needy
adult patients with T2D to improve their life experiences
and HRQoL.
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